Navigation Links


Cyto at medicine news

Cytobrush to detect oral cancer

Dentists now have an easy painfree way to detect oral cancer at its earliest stages. Cytobrush biopsy, is a technique which underwent clinical trials at the University of Philadelphia//School of Dental Medicine that showed it to be a significant advance over previous cytology (PAP smear-type) tests. According to Martin S. Greenberg, professor and chairman or oral medicine early detectio...

A better test than cytology for Urinary Malignancy

A new method has been found for detecting upper urinary tract transitional cell carcinoma by a team of researchers working Kingston, Ontario, Canada. This method checks for fibrinogen/fibrin degradation products. It appears to be more effective and accurate when compared to standard urinary cytology. The Researchers compared the efficacy of two types of rapid urine tests with urine cytolo...

Leptin and inflammatory cytokines in women with pre-eclampsia

Recent research shows that in women with pre-eclampsia, the level of maternal serum leptin is increased and correlates positively with the level of inflammatory cytokines, TNF-á//. The research was conducted at University Hospital of Puerto Real, Cadiz, Spain to compare maternal serum leptin concentration in women with pre-eclampsia and women with normal pregnancy, and to evaluate the r...

Creation of Cytomegalovirus Vaccine by an Innovative Method

Human cytomegalovirus, or CMV infects about 40,000 children before birth and about 8,000 of these children suffer permanent disabilities due to the virus – almost one an hour.// Such disabilities can include vision loss, hearing loss, mental disability, a lack of coordination, and seizures. According to the Centers for Disease Control and Prevention, CMV is as common a cause of serious...

Innovative Method for Creating a Human Cytomegalovirus Vaccine Outlined

Each year, about 40,000 children are born infected with human cytomegalovirus, or CMV, and about 8,000 of these children suffer permanent disabilities due to the virus – almost one an hour. These disabilities// can include hearing loss, vision loss, mental disability, a lack of coordination, and seizures. According to the Centers for Disease Control and Prevention, CMV is as common a caus...

Experimental Drug Causes Cytokine Storm

A clinical trail with an experimental drug designed to treat chronic inflammatory conditions and leukemia resulted in an immune system overreaction leading// to six British men involved in the trail becoming seriously ill. All the six men have since recovered from the drug reaction. Dr. Ganesh Suntharalingam and colleagues at Northwick Park Hospital in northwest London said the immun...

Drexel Research in Cytokines Could Treat Sepsis

Researchers from Drexel University and the University of Brighton in the U.K. have achieved groundbreaking results, which may significantly improve the treatment of sepsis. // Sepsis is an uncontrolled immune response to infection or severe trauma that results in 1,500 deaths worldwide every day, a scale comparable to those caused by lung and breast cancers. Sepsis occurs when prote...

Drug Boosts Platelet Production, Reversing Immune Thrombocytopenic Purpura

Attacking a platelet-depleting autoimmune disease in a whole new way, an experimental drug is helping patients with immune thrombocytopenic purpura (ITP) once again// produce healthy amounts of platelets -- with no major side effects. That's the conclusion of a new, multicenter study led by Dr. James B. Bussel, professor of pediatrics at Weill Cornell Medical College, attending pediat...

Cytokine Resistance Contributes to Pathology of Type 2 Diabetes

A new study by University of Illinois researchers describes how an impaired anti-inflammatory response plays a role in the pathology of type 2 diabetes . Published in the Journal of Immunology, the study focused on a number of cytokines, protein signals that bind to specific receptors on cells and set off a cascade of biochemical reactions within the cell. Interleukins...

Cytokine IL6 as a New Chemotherapeutic Target for Ras-driven Cancers

Dr. Christopher Counter and colleagues at the Duke University Medical Center have identified IL6 as a new target in the battle against Ras-induced cancers . Ras is a key intracellular messenger protein that directs, among other things, cell growth and proliferation. Over-expression of the Ras oncogene, or of its growth-promoting pathway, is an integral step in the development of a numb...
Other TagsTABTABTABTABTABTABTABTABTABReFORMReFORMReFORM
(Date:10/10/2008)...n a previously unknown relationship between stem c...ondria a cell,s energy makers. Stem cells with mor... to differentiate and are more likely to form tumo...C, could lead to methods of enriching the best ste...may provide some insights into the role of stem ce...
(Date:10/10/2008)...E, MADISON Governor Jim Doyle today announced a h...rch institutions to advance personalized health ca...es diseases. The Wisconsin Genomics Initiative is ...ld Clinic, Medical College of Wisconsin (MCW), Uni... Health (UWSMPH) and UW-Milwaukee (UWM). , Wisco...
(Date:10/10/2008)...ng the 1950s, Austrian and Swiss scientists conduc...al taking photographs of the glaciers, mountains a...logist Fritz Mller spent eight months in the regio...tographing the Himalayan glaciers. , Now, fifty ... by these scientists are of immense value in tryin...
(Date:10/10/2008)...able in German . , DNA, the molecule that act...ms of life, is highly resistant against alteration...nism for its photostability presents some puzzling... the four chemical bases that make up the DNA mole...d in showing that DNA strands differ in their ligh...
Breaking Biology News(10 mins):Governor Doyle announces historic genomic research collaboration 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 3Can genetic information be controlled by light? 2At Annual and Special Meeting of Shareholders Neurochem to officially adopt new name BELLUS Health And to provide update on programs including f 16805 1At Annual and Special Meeting of Shareholders Neurochem to officially adopt new name BELLUS Health And to provide update on programs including f 16805 2At Annual and Special Meeting of Shareholders Neurochem to officially adopt new name BELLUS Health And to provide update on programs including f 16805 3At Annual and Special Meeting of Shareholders Neurochem to officially adopt new name BELLUS Health And to provide update on programs including f 16805 4At Annual and Special Meeting of Shareholders Neurochem to officially adopt new name BELLUS Health And to provide update on programs including f 16805 5At Annual and Special Meeting of Shareholders Neurochem to officially adopt new name BELLUS Health And to provide update on programs including f 16805 6Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A NPHC PECD PNRR 4595 1Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A NPHC PECD PNRR 4595 2Featured Stocks on Todays Edition of WallSt nets 3 Minute Press Show 3A NPHC PECD PNRR 4595 3Pharmacopeia Announces Upcoming Late Breaker Presentation of Phase 2a Results for Its First in Class Investigational DARA Compound PS433540 1786 1Pharmacopeia Announces Upcoming Late Breaker Presentation of Phase 2a Results for Its First in Class Investigational DARA Compound PS433540 1786 2Pharmacopeia Announces Upcoming Late Breaker Presentation of Phase 2a Results for Its First in Class Investigational DARA Compound PS433540 1786 3Pharmacopeia Announces Upcoming Late Breaker Presentation of Phase 2a Results for Its First in Class Investigational DARA Compound PS433540 1786 4Heritage Announces 2410 Million Financing 16801 1Heritage Announces 2410 Million Financing 16801 2
(Date:10/10/2008)...n on those already on drugs, some diagnoses could ... (HealthDay News) -- A new study questions the com...icile ( C. difficile ) infections are always prece...l University and the Jewish General Hospital found...ho acquired C. difficile infections before hospi...
(Date:10/10/2008)...ct. 10 /PRNewswire-FirstCall/ -- Synvista,Therapeu...ointed William,(Bill) Federici, 49, to its Board o... Mr. Federici joined West Pharmaceutical Services...August of 2003. Under his financial leadership,We...an $1.0 billion from,$300 million. He has more tha...
(Date:10/10/2008)...t. 10 /PRNewswire/ -- Do you think that the blind,...town? Attend the October,17 open house at the Virg...n Impaired, and see how instructors there empower ..., fulfilling lives through non-visual,techniques t...Azalea Avenue, is holding an open house to,celebra...
(Date:10/10/2008)... Upon the completion of a highly successful CI...ia proudly announces their next business technolog...echnology executives in healthcare. CDM Media has ...y 10-12, 2009 at the Four Seasons Resort in Scotts...(PRWEB) October 11, 2008 -- Upon the completion of...
Breaking Medicine News(10 mins):Health News:Antibiotics May Not Cause Diarrheal Bacteria 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2
Other Contentspumppumppumppumppumppumppumppumppumpprotonprotonprotonprotonprotonprotonprotozoaprotozoaprotozoaprotozoaprotozoapseudopodpurineequilibriumequilibriumequilibriumequilibriumequilibriumequilibriumpunctuatedpunctuatedpyrimidine